Merck's stock upgraded on theory drugmaker is 'insulated from trade-related volatility'CNBC • 05/13/19
Merck & Co Inc. (MRK) CEO Ken Frazier on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/30/19
Merck's Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study resultsMarket Watch • 04/26/19
Merck's Keytruda + Galectin's Belapectin (GR-MD-02): Thoughts On The EvidenceSeeking Alpha • 04/17/19
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New DealZacks Investment Research • 04/12/19